title: Dopamine agonist therapy and cardiac valve dysfunction.
authors.affiliation: Department of Endocrinology, Division of Medical Sciences, University of Birmingham, UK.
authors.forename: Mark
authors.initials: M
authors.lastname: Sherlock
authors.forename: Richard
authors.initials: R
authors.lastname: Steeds
authors.forename: Andy A
authors.initials: AA
authors.lastname: Toogood
mesh_terms: D018491:Dopamine Agonists / Q000009:adverse effects* / Q000378:metabolism; D005347:Fibroblasts / Q000378:metabolism / Q000473:pathology; D005355:Fibrosis; D006351:Heart Valves / Q000378:metabolism / Q000473:pathology*; D006801:Humans; D006966:Hyperprolactinemia / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology; D010300:Parkinson Disease / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology; D011985:Receptors, Serotonin / Q000378:metabolism
chemical_list: C098814:5HT-dro2B receptor; D018491:Dopamine Agonists; D011985:Receptors, Serotonin